Dan Roden
We are interested in understanding the role of genetic variation in two distinct domains: in susceptibility to abnormal heart rhythms and response to antiarrhythmic therapies, and in the broader question of how genetic variation modulates drug responses. We use models from iPS cells to large scale studies in BioVU, Vanderbilt’s biobank.
We are interested in understanding the role of genetic variation in two distinct domains: in susceptibility to abnormal heart rhythms and response to antiarrhythmic therapies, and in the broader question of how genetic variation modulates drug responses. We use models from iPS cells to large scale studies in BioVU, Vanderbilt’s biobank.
Keywords: pharmacogenetics , arrhythmias , stem cells , genomics
Research Area: Drug Design , Computational and Systems Biology , Stem Cell Biology & Regeneration , Genomics , Cardiovascular Biology